Skip to main content

Volume 15 Supplement 1

Immunotherapy Bridge and Melanoma Bridge 2016: meeting abstracts

Meeting abstracts

Publication charges for this supplement were funded by 3P Solution, Milan, Italy. PAA has acted in a consultant/advisory role for BMS, Roche-Genentech, MSD, Novartis, Amgen, Array, Merck-Serono, Pierre-Fabre and has received research funding from BMS, Roche-Genentech, Array. RD has acted in a consultant/advisory role for Novartis, MSD, BMS, Roche, GSK, Amgen and Takeda and has received research funding from Novartis, MSD, BMS, Roche and GSK. MP has acted in a consultant/advisory role for BMS and Novartis and has received honoraria and research funding from BMS and Merck. IP, GP and MT declare that they have no competing interests.

Naples, Italy30 November - 3 December 2016

Conference website​​​​​​​

Edited by Paolo A. Ascierto, Reinhard Dummer, Giuseppe Palmieri, Michael Postow, Igor Puzanov and Magdalena Thurin. 

  1. Authors: Vera Hirsh, Sandro Pignata, Melissa Bersanelli, Letizia Gnetti, Cinzia Azzoni, Lorena Bottarelli, Donatello Gasparro, Francesco Leonardi, Enrico Maria Silini, Sebastiano Buti, Erik Wennerberg, Aranzazu Mediero, Bruce Cronstein, Silvia Formenti, Sandra Demaria, Claire Vanpouille-Box…
    Citation: Journal of Translational Medicine 2017 15(Suppl 1):8

Annual Journal Metrics

  • 2022 Citation Impact
    7.4 - 2-year Impact Factor
    6.9 - 5-year Impact Factor
    1.458 - SNIP (Source Normalized Impact per Paper)
    1.544 - SJR (SCImago Journal Rank)

    2023 Speed
    9 days submission to first editorial decision for all manuscripts (Median)
    86 days submission to accept (Median)

    2023 Usage 
    4,999,990 downloads
    8,678 Altmetric mentions